Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Centessa Pharmaceuticals plc | 45,000 | reported | 02 Feb 2026 | tx 4+1,076,000 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 5,599 | reported | 01 Oct 2016 | tx 29+27,359−8,876 |
| Fusion Pharmaceuticals Inc. | 0 | reported | 04 Jun 2024 | tx 20+861,595−1,174,954 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Centessa Pharmaceuticals plc | 45,000 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | Centessa Pharmaceuticals plc | 181,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Centessa Pharmaceuticals plc | 250,000 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Centessa Pharmaceuticals plc | 600,000 | 0.00 USD | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 10,410 | — | |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 38,561 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 26,972 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 60,852 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 138,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 63,700 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 250,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 106,100 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 313,359 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 167,000 | — | deriv |
| 04 Jan 2024 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 106,100 | 0.00 USD | deriv |
| 04 Jan 2024 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 63,700 | 0.00 USD | deriv |
| 05 Jan 2023 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 250,000 | 0.00 USD | deriv |
| 31 Aug 2021 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 3,910 | — | |
| 01 Feb 2022 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 167,000 | 0.00 USD | deriv |
| 04 Feb 2021 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 138,000 | 0.00 USD | deriv |
| 30 Jun 2020 | PURCHASE | Fusion Pharmaceuticals Inc. | 6,500 | 17.00 USD | |
| 06 Feb 2020 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 38,561 | 0.00 USD | deriv |
| 25 Jun 2020 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 26,972 | 0.00 USD | deriv |
| 25 Jun 2020 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 60,852 | 0.00 USD | deriv |
| 01 Oct 2016 | TAX_WITHHOLDING | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 284 | 83.34 USD |